Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
about
Predictive models of type 1 diabetes progression: understanding T-cell cycles and their implications on autoantibody releaseA molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritisInvestigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction.On-chip activation and subsequent detection of individual antigen-specific T cells.Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseManipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.T cell avidity and tumor immunity: problems and solutionsMHC class II tetramersHigh prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responsesConcurrent detection of secreted products from human lymphocytes by microengraving: cytokines and antigen-reactive antibodiesMHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8(+) T Lymphocytes.Transient regulatory T-cells: a state attained by all activated human T-cells.Molecular basis for T cell response induced by altered peptide ligand of type II collagen.Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes.Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?Tracking epitope-specific T cells.The pathogenesis and natural history of type 1 diabetes.Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure.Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune controlCurrent approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.T cell recognition of autoantigens in human type 1 diabetes: clinical perspectivesThe targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.Production of primary human CD4⁺ T cell lines and clones.T cell receptor signaling induced by an analog peptide of type II collagen requires activation of Syk.Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritisAntigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks?Efficient expansion of cryopreserved CD4(+)CD25(+)CD127(lo/-) cells in Type 1 diabetes.Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8+ T cells.CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.Recent insights into CD4+T-cell specificity and function in Type 1 diabetes
P2860
Q27312237-9351F339-A1B1-4C72-96D4-196ACDB4C105Q27680522-6D3F71DA-D323-494E-9C10-282EE4531C5DQ30500186-34A3F71C-D04A-4BF8-8A7B-9475495424F6Q33689693-8F5E5576-ADFC-4678-8104-64DEFF9A9BE4Q33729769-0349253F-F50F-458B-A5C6-B09A16B4E813Q33838467-22864BBF-BCDD-42EA-84ED-97275731E3A0Q34115960-5D721041-1C1A-468F-B56C-8C2B10290C1DQ34258556-2AB02F3F-8F6A-4997-BC7F-141905A611CEQ34501474-38C268FB-D3BC-4A02-BBD6-AB921DC4FE89Q34803611-068D92F2-643D-4366-8004-C8BA6659220BQ34984511-8D976AC9-19C9-49B5-9B65-96B0ED9EE290Q35091432-67F0995F-D9D6-47EF-9E4F-690DD5FC7CD9Q35605653-2BDE0818-9D9B-4310-9F74-C9C0C7A98605Q35683291-2A7FF3CE-2BDE-4AFA-8638-13259E98B76BQ35792962-DD06FC1F-3518-4E33-84F3-7B0225A8254EQ36003945-2CA286A8-85CD-441A-8302-920433C7C77EQ36010973-5F09B402-0CAE-440E-A4B4-91C7BDFB43A4Q36054301-B4BD9824-9FE2-4C4A-85C8-F3D6A836FB6DQ36171406-2E581983-C372-41F4-9602-4875C35D2C15Q36454999-7849B7CF-0112-4BC0-81DB-E4635C525000Q36526611-48635523-A8D1-4292-A5C4-9CD9641762D0Q37019142-3B030886-9DB0-41AD-9865-93DFCB316622Q37077802-1EDABBD0-333B-461B-8736-2157C615334AQ37682303-26777B36-8930-43D3-B252-DE9091583E2FQ37789411-61D080B4-4327-4169-A029-BC32631C7E9FQ37904710-3EC00E2D-7F4F-47C4-916F-135D225CACCCQ38134108-A18CF20D-DD90-42E7-8CBF-CF6FD70CC374Q39208659-403EFFE2-A36B-476C-8621-95428D4FCF19Q42086872-BD0FAAE4-DCBC-405F-AB02-90FDE0151C5FQ42326335-FD88BA6D-3F0B-49E9-B6D6-6263FFCDC2ABQ42739489-E8AE3E47-6226-496A-9C0C-110FD0F5AE92Q42961664-9DAB42B8-F988-4E3B-94E8-5B663426E4A9Q47560120-47675C1A-B2AA-4A28-B6A9-141F3F1A7C21Q51327462-E67E1147-A7C1-48DB-9A50-A581D459BAC1Q58233277-A23CA757-F2F8-4BCB-A045-C9C3B4475C7F
P2860
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@ast
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@en
type
label
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@ast
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@en
prefLabel
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@ast
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@en
P2093
P2860
P1433
P1476
Functional avidity directs T-cell fate in autoreactive CD4+ T cells.
@en
P2093
Bryan Carson
Gerald T Nepom
Helena Reijonen
Sharon A Kochik
Steven F Ziegler
William W Kwok
P2860
P304
P356
10.1182/BLOOD-2004-12-4848
P407
P577
2005-07-19T00:00:00Z